281 related articles for article (PubMed ID: 18781661)
1. Extinction retention predicts improvement in social anxiety symptoms following exposure therapy.
Berry AC; Rosenfield D; Smits JA
Depress Anxiety; 2009; 26(1):22-7. PubMed ID: 18781661
[TBL] [Abstract][Full Text] [Related]
2. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.
Hofmann SG; Meuret AE; Smits JA; Simon NM; Pollack MH; Eisenmenger K; Shiekh M; Otto MW
Arch Gen Psychiatry; 2006 Mar; 63(3):298-304. PubMed ID: 16520435
[TBL] [Abstract][Full Text] [Related]
3. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.
Ressler KJ; Rothbaum BO; Tannenbaum L; Anderson P; Graap K; Zimand E; Hodges L; Davis M
Arch Gen Psychiatry; 2004 Nov; 61(11):1136-44. PubMed ID: 15520361
[TBL] [Abstract][Full Text] [Related]
4. A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy.
Norberg MM; Krystal JH; Tolin DF
Biol Psychiatry; 2008 Jun; 63(12):1118-26. PubMed ID: 18313643
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial of the effect of D-cycloserine on exposure therapy for spider fear.
Guastella AJ; Dadds MR; Lovibond PF; Mitchell P; Richardson R
J Psychiatr Res; 2007 Sep; 41(6):466-71. PubMed ID: 16828803
[TBL] [Abstract][Full Text] [Related]
6. Facilitation of fear extinction in phobic participants with a novel cognitive enhancer: a randomized placebo controlled trial of yohimbine augmentation.
Powers MB; Smits JA; Otto MW; Sanders C; Emmelkamp PM
J Anxiety Disord; 2009 Apr; 23(3):350-6. PubMed ID: 19223151
[TBL] [Abstract][Full Text] [Related]
7. Does yohimbine hydrochloride facilitate fear extinction in virtual reality treatment of fear of flying? A randomized placebo-controlled trial.
Meyerbroeker K; Powers MB; van Stegeren A; Emmelkamp PM
Psychother Psychosom; 2012; 81(1):29-37. PubMed ID: 22116378
[TBL] [Abstract][Full Text] [Related]
8. Does the form or the amount of exposure make a difference in the cognitive-behavioral therapy treatment of social phobia?
Borgeat F; Stankovic M; Khazaal Y; Rouget BW; Baumann MC; Riquier F; O'Connor K; Jermann F; Zullino D; Bondolfi G
J Nerv Ment Dis; 2009 Jul; 197(7):507-13. PubMed ID: 19597358
[TBL] [Abstract][Full Text] [Related]
9. Enhancing exposure therapy for anxiety disorders with glucocorticoids: from basic mechanisms of emotional learning to clinical applications.
Bentz D; Michael T; de Quervain DJ; Wilhelm FH
J Anxiety Disord; 2010 Mar; 24(2):223-30. PubMed ID: 19962269
[TBL] [Abstract][Full Text] [Related]
10. Yohimbine enhancement of exposure therapy for social anxiety disorder: a randomized controlled trial.
Smits JA; Rosenfield D; Davis ML; Julian K; Handelsman PR; Otto MW; Tuerk P; Shiekh M; Rosenfield B; Hofmann SG; Powers MB
Biol Psychiatry; 2014 Jun; 75(11):840-6. PubMed ID: 24237691
[TBL] [Abstract][Full Text] [Related]
11. Screening for social anxiety disorder with the self-report version of the Liebowitz Social Anxiety Scale.
Rytwinski NK; Fresco DM; Heimberg RG; Coles ME; Liebowitz MR; Cissell S; Stein MB; Hofmann SG
Depress Anxiety; 2009; 26(1):34-8. PubMed ID: 18781659
[TBL] [Abstract][Full Text] [Related]
12. Treating university students with social phobia and public speaking fears: Internet delivered self-help with or without live group exposure sessions.
Tillfors M; Carlbring P; Furmark T; Lewenhaupt S; Spak M; Eriksson A; Westling BE; Andersson G
Depress Anxiety; 2008; 25(8):708-17. PubMed ID: 18729147
[TBL] [Abstract][Full Text] [Related]
13. The repeated confrontation with videotapes of spiders in multiple contexts attenuates renewal of fear in spider-anxious students.
Vansteenwegen D; Vervliet B; Iberico C; Baeyens F; Van den Bergh O; Hermans D
Behav Res Ther; 2007 Jun; 45(6):1169-79. PubMed ID: 17045959
[TBL] [Abstract][Full Text] [Related]
14. Emotional variability and sustained arousal during exposure.
Culver NC; Stoyanova M; Craske MG
J Behav Ther Exp Psychiatry; 2012 Jun; 43(2):787-93. PubMed ID: 22123332
[TBL] [Abstract][Full Text] [Related]
15. Optimizing inhibitory learning during exposure therapy.
Craske MG; Kircanski K; Zelikowsky M; Mystkowski J; Chowdhury N; Baker A
Behav Res Ther; 2008 Jan; 46(1):5-27. PubMed ID: 18005936
[TBL] [Abstract][Full Text] [Related]
16. A confirmatory factor analysis of a self-report version of the Liebowitz Social Anxiety Scale.
Oakman J; Van Ameringen M; Mancini C; Farvolden P
J Clin Psychol; 2003 Jan; 59(1):149-61. PubMed ID: 12508338
[TBL] [Abstract][Full Text] [Related]
17. A prospective examination of predictors of post-event processing following videotaped exposures in group cognitive behavioural therapy for individuals with social phobia.
Laposa JM; Rector NA
J Anxiety Disord; 2011 May; 25(4):568-73. PubMed ID: 21330099
[TBL] [Abstract][Full Text] [Related]
18. Extinction treatment in multiple contexts attenuates ABC renewal in humans.
Balooch SB; Neumann DL; Boschen MJ
Behav Res Ther; 2012 Oct; 50(10):604-9. PubMed ID: 22835841
[TBL] [Abstract][Full Text] [Related]
19. The relative contributions of fear and disgust reductions to improvements in spider phobia following exposure-based treatment.
Olatunji BO; Huijding J; de Jong PJ; Smits JA
J Behav Ther Exp Psychiatry; 2011 Mar; 42(1):117-21. PubMed ID: 20732677
[TBL] [Abstract][Full Text] [Related]
20. Challenges to the traditional exposure paradigm: variability in exposure therapy for contamination fears.
Kircanski K; Mortazavi A; Castriotta N; Baker AS; Mystkowski JL; Yi R; Craske MG
J Behav Ther Exp Psychiatry; 2012 Jun; 43(2):745-51. PubMed ID: 22104655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
